• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why TransCode Therapeutics Shares Are Trading Lower By Over 24%? Here Are Other Stocks Moving In Friday's Mid-Day Session

    1/19/24 1:05:18 PM ET
    $ABSI
    $ADAG
    $AGAE
    $AGFY
    Biotechnology: Commercial Physical & Biological Resarch
    Health Care
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $ABSI alert in real time by email

    Shares of TransCode Therapeutics, Inc. (NASDAQ:RNAZ) fell sharply during Friday’s session.

    TransCode Therapeutics priced a 5,942,623 share common stock offering at $1.22 per share.

    TransCode Therapeutics shares dipped 24.3% to $0.8248 on Friday.

    Here are some other stocks moving in today's mid-day session.

    Gainers

    • Charge Enterprises, Inc. (NASDAQ:CRGE) shares surged 105.4% to $0.2510.
    • Kaman Corporation (NASDAQ:KAMN) shares climbed 101.3% to $45.14 after the company announced it will be acquired by Arcline for $1.8 billion.
    • Mesa Air Group Inc (NASDAQ:MESA) gained 70.4% to $1.09 as the company entered into new agreements with United Airlines for improved operating and financing terms.
    • Edgewise Therapeutics, Inc. (NASDAQ:EWTX) rose 37.3% to $13.30 after the company announced pricing of its $240 million underwritten offering of 21,818,182 shares at $11 per share.
    • Processa Pharmaceuticals, Inc. (NASDAQ:PCSA) climbed 34.2% to $0.2725. Processa Pharmaceuticals announced plans to expand the development of next generation capecitabine (NGC-Cap) into advanced or metastatic breast cancer beginning with next Phase 2 trial in breast cancer.
    • Tricon Residential Inc. (NYSE:TCN) shares gained 28.2% to $11.06 Blackstone and Tricon Residential entered into an arrangement agreement under which Blackstone Real Estate Partners X together with Blackstone Real Estate Income Trust, Inc. will acquire all outstanding common shares of Tricon for $11.25 per share in cash.
    • Spirit Airlines, Inc. (NYSE:SAVE) jumped 24% to $7.06 after the company announced preliminary fourth-quarter and full year 2023 estimates, issued first-quarter 2024 guidance and said the merger agreement between the company and JetBlue "remains in full force and effect."
    • Super Micro Computer, Inc. (NASDAQ:SMCI) climbed 23.1% to $383.31 after the company announced updated financial guidance for the second-quarter, which surpassed its previous outlook.
    • Allied Gaming & Entertainment Inc. (NASDAQ:AGAE) rose 20.6% to $1.1190.
    • Portage Biotech Inc. (NASDAQ:PRTG) gained 19% to $1.14.
    • ProMIS Neurosciences, Inc. (NASDAQ:PMN) gained 19% to $2.07.
    • Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ:SHPH) gained 16.4% to $0.5185.
    • Treasure Global Inc. (NASDAQ:TGL) shares rose 14.2% to $0.1176. Treasure Global and AIO Synergy recently entered into a strategic alliance aimed at reshaping the landscape of artificial intelligence.
    • Silk Road Medical, Inc (NASDAQ:SILK) jumped 13.1% to $14.91 after Stifel upgraded the stock from Hold to Buy and raised its price target from $9 to $20.
    • Wayfair Inc. (NYSE:W) jumped 11.6% to $56.81 after the company announced a workforce realignment plan, which includes a workforce reduction involving approximately 13% of its global workforce.
    • Bullfrog AI Holdings, Inc. (NASDAQ:BFRG) gained 10.6% to $4.30.
    • NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS) rose 10.5% to $19.44.
    • World Acceptance Corporation (NASDAQ:WRLD) gained 10.2% to $134.00 following upbeat quarterly results.
    • Ally Financial Inc. (NYSE:ALLY) gained 9.4% to $35.15. Synchrony Financial announced plans to acquire Ally Financial's point of sale financing business. Ally Financial also posted upbeat quarterly sales.
    • Cyngn Inc. (NASDAQ:CYN) surged 8.8% to $0.1468 after gaining over 5% on Thursday.
    • Mesoblast Limited (NASDAQ:MESO) gained 8.1% to $1.86 after the FDA granted a Rare Pediatric Disease Designation to the company’s Revascor® for treating children with congenital heart disease.
    • WNS (Holdings) Limited (NYSE:WNS) rose 4.4% to $65.71. Needham analyst Mayank Tandon maintained WNS with a Buy and raised the price target from $80 to $85.

    Losers

    • C3is Inc. (NASDAQ:CISS) shares fell 63.2% to $0.1384 as the company announced pricing of $7.0 million upsized underwritten public offering.
    • Azitra, Inc. (NYSE:AZTR) dipped 31.8% to $1.3976 after the company filed for a firm commitment public offering of 3 million shares of common stock.
    • iRobot Corporation (NASDAQ:IRBT) fell 30% to $16.53 following a report suggesting the EU plans to block Amazon's acquisition of the company.
    • Accelerate Diagnostics, Inc. (NASDAQ:AXDX) fell 27.1% to $1.17 after the company reported pricing of approximately $15 million public offering and private placement.
    • AST SpaceMobile, Inc. (NASDAQ:ASTS) declined 24.3% to $3.15. AST SpaceMobile announced a $100 million offering of common stock. The company also announced a strategic investment from AT&T Inc (NYSE:T),
    • Alphabet Inc (NASDAQ:GOOG) (NASDAQ:GOOGL) and Vodafone.
    • Agrify Corporation (NASDAQ:AGFY) dipped 21.9% to $1.0699. Agrify entered into a multi-million dollar sales agreement with Ocean Deep/Golden Lake Business Park.
    • Adagene Inc. (NASDAQ:ADAG) fell 21.6% to $2.64.
    • BioCardia, Inc. (NASDAQ:BCDA) fell 20% to $0.46.
    • Volato Group, Inc. (NYSE:SOAR) fell 17.2% to $2.1688.
    • Datasea Inc. (NASDAQ:DTSS) shares fell 16.4% to $0.1140. Datasea announced plans for a 1-for-15 reverse stock split to regain compliance with Nasdaq minimum bid requirement.
    • Orgenesis Inc. (NASDAQ:ORGS) dipped 15.3% to $0.2711.
    • Wheels Up Experience Inc. (NYSE:UP) fell 12.6% to $3.19.
    • Nkarta, Inc. (NASDAQ:NKTX) fell 12.2% to $7.47.
    • Vision Marine Technologies Inc. (NASDAQ:VMAR) shares fell 11.5% to $0.7098. Vision Marine Technologies announced close of $3.0 million private placement of convertible preferred shares and warrants with Investissement Québec.
    • Absci Corporation (NASDAQ:ABSI) dipped 11.3% to $3.2120.
    • Lithium Americas Corp. (NYSE:LAC) fell 10.4% to $4.3650.
    • Celsius Holdings, Inc. (NASDAQ:CELH) fell 10% to $53.60 after B of A Securities downgraded the stock from Buy to Neutral and announced a $65 price target.
    • Hut 8 Corp. (NYSE:HUT) dipped 9.4% to $6.45.
    • Lifezone Metals Limited (NYSE:LZM) fell 9.3% to $6.37.
    • MorphoSys AG (NASDAQ:MOR) fell 7.3% to $9.49 after falling 6% on Wednesday. Morgan Stanley analyst James Quigley, on Tuesday, downgraded MorphoSys from Overweight to Equal-Weight.
    • Hertz Global Holdings, Inc. (NASDAQ:HTZ) declined 6.6% to $8.40 after Jefferies downgraded the stock from Buy to Hold and lowered its price target from $12 to $8.
    • Esperion Therapeutics, Inc. (NASDAQ:ESPR) shares fell 6.1% to $2.0188. Esperion priced its $85.1 million public offering of 56.7 million common share at $1.50 per share.
    • Chegg, Inc. (NYSE:CHGG) shares fell 6.1% to $9.45. Goldman Sachs analyst Eric Sheridan downgraded Chegg from Neutral to Sell and lowered the price target from $10 to $8.

     

    Now Read This: Jim Cramer Predicts A 'Terrific Year' For This Manufacturer, And As For U-Haul? 'I'm Fine With It'

    Get the next $ABSI alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ABSI
    $ADAG
    $AGAE
    $AGFY

    CompanyDatePrice TargetRatingAnalyst
    Alphabet Inc.
    $GOOG
    2/5/2026$400.00 → $420.00Buy
    Pivotal Research Group
    Hut 8 Corp.
    $HUT
    2/2/2026$80.00Buy
    H.C. Wainwright
    Alphabet Inc.
    $GOOGL
    1/26/2026$330.00 → $360.00Overweight
    KeyBanc Capital Markets
    Alphabet Inc.
    $GOOGL
    1/23/2026$333.00 → $346.00Buy
    Stifel
    Alphabet Inc.
    $GOOG
    1/22/2026$400.00Outperform → Strong Buy
    Raymond James
    Alphabet Inc.
    $GOOG
    1/13/2026$350.00 → $355.00Buy
    TD Cowen
    Super Micro Computer Inc.
    $SMCI
    1/13/2026$26.00Sell
    Goldman
    AST SpaceMobile Inc.
    $ASTS
    1/13/2026$105.00Buy → Neutral
    B. Riley Securities
    More analyst ratings

    $ABSI
    $ADAG
    $AGAE
    $AGFY
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for NEXLIZET issued to ESPERION THERAPS INC

    Submission status for ESPERION THERAPS INC's drug NEXLIZET (SUPPL-16) with active ingredient BEMPEDOIC ACID; EZETIMIBE has changed to 'Approval' on 03/22/2024. Application Category: NDA, Application Number: 211617, Application Classification: Efficacy

    3/25/24 4:41:30 AM ET
    $ESPR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for NEXLIZET issued to ESPERION THERAPS INC

    Submission status for ESPERION THERAPS INC's drug NEXLIZET (SUPPL-17) with active ingredient BEMPEDOIC ACID; EZETIMIBE has changed to 'Approval' on 03/22/2024. Application Category: NDA, Application Number: 211617, Application Classification: Efficacy

    3/25/24 4:41:37 AM ET
    $ESPR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for NEXLETOL issued to ESPERION THERAPS INC

    Submission status for ESPERION THERAPS INC's drug NEXLETOL (SUPPL-13) with active ingredient BEMPEDOIC ACID has changed to 'Approval' on 03/22/2024. Application Category: NDA, Application Number: 211616, Application Classification: Efficacy

    3/25/24 4:41:29 AM ET
    $ESPR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ABSI
    $ADAG
    $AGAE
    $AGFY
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Ally Financial to present at the RBC Capital Markets Financial Institutions Conference

    CHARLOTTE, N.C., Feb. 19, 2026 /PRNewswire/ -- Ally Financial Inc. (NYSE:ALLY) Chief Financial Officer Russ Hutchinson will present at the RBC Capital Markets Financial Institutions Conference on Tuesday, March 10, 2026 at approximately 9:20 a.m. ET. A live webcast will be available on the day of the conference at http://www.ally.com/about/investor/ under the Events and Presentations section of the Investor Relations website. A replay will also be available.About Ally Financial Ally Financial Inc. (NYSE:ALLY) is a financial services company with the nation's largest all-digital

    2/19/26 10:00:00 AM ET
    $ALLY
    Major Banks
    Finance

    C3is Inc. reports fourth quarter and twelve months 2025 financial and operating results

    ATHENS, Greece, Feb. 19, 2026 (GLOBE NEWSWIRE) -- C3is Inc. (NASDAQ:CISS) (the "Company"), a ship-owning company providing drybulk and tanker seaborne transportation services, announced today its unaudited financial and operating results for the fourth quarter and twelve months ended December 31, 2025. OPERATIONAL AND FINANCIAL HIGHLIGHTS Our handysize dry bulk carriers are on time charters of short-term durations, producing steady cash flows, while our Aframax tanker operates in the spot market, currently achieving voyage charter rates of around $60,000 per day.All of our vessels are unencumbered.Fleet operational utilization of 93.5% for the three months ended December 31, 2025, compar

    2/19/26 9:10:00 AM ET
    $CISS
    Marine Transportation
    Consumer Discretionary

    C3is Inc. reports fourth quarter and twelve months 2025 financial and operating results

    ATHENS, Greece, Feb. 19, 2026 (GLOBE NEWSWIRE) -- C3is Inc. (NASDAQ:CISS) (the "Company"), a ship-owning company providing drybulk and tanker seaborne transportation services, announced today its unaudited financial and operating results for the fourth quarter and twelve months ended December 31, 2025. OPERATIONAL AND FINANCIAL HIGHLIGHTS Our handysize dry bulk carriers are on time charters of short-term durations, producing steady cash flows, while our Aframax tanker operates in the spot market, currently achieving voyage charter rates of around $60,000 per day.All of our vessels are unencumbered.Fleet operational utilization of 93.5% for the three months ended December 31, 2025, compar

    2/19/26 9:10:00 AM ET
    $CISS
    Marine Transportation
    Consumer Discretionary

    $ABSI
    $ADAG
    $AGAE
    $AGFY
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    CEO & President Stankey John T converted options into 65,128 shares and covered exercise/tax liability with 24,098 shares, increasing direct ownership by 26% to 199,244 units (SEC Form 4)

    4 - AT&T INC. (0000732717) (Issuer)

    2/18/26 5:43:04 PM ET
    $T
    Telecommunications Equipment
    Telecommunications

    SVP-ChiefActngOfcr&Controller Sabrina Sanders S converted options into 7,632 shares and covered exercise/tax liability with 2,999 shares, increasing direct ownership by 3% to 170,227 units (SEC Form 4)

    4 - AT&T INC. (0000732717) (Issuer)

    2/18/26 5:41:42 PM ET
    $T
    Telecommunications Equipment
    Telecommunications

    Chief Operating Officer Mcelfresh Jeffery S. converted options into 30,059 shares and covered exercise/tax liability with 11,122 shares, increasing direct ownership by 3% to 718,210 units (SEC Form 4)

    4 - AT&T INC. (0000732717) (Issuer)

    2/18/26 5:39:41 PM ET
    $T
    Telecommunications Equipment
    Telecommunications

    $ABSI
    $ADAG
    $AGAE
    $AGFY
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    PRESIDENT, CEO, EXEC CHAIRMAN Rosensweig Daniel bought $56,360 worth of shares (100,000 units at $0.56), increasing direct ownership by 1% to 7,625,075 units (SEC Form 4)

    4 - CHEGG, INC (0001364954) (Issuer)

    2/18/26 6:30:27 AM ET
    $CHGG
    Other Consumer Services
    Real Estate

    Large owner Abg Management Ltd. bought $8,499,988 worth of shares (700,741 units at $12.13) (SEC Form 4)

    4 - ProMIS Neurosciences Inc. (0001374339) (Issuer)

    2/5/26 7:00:01 PM ET
    $PMN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    President and CEO Altman Peter bought $5,650 worth of shares (5,000 units at $1.13), increasing direct ownership by 2% to 273,866 units (SEC Form 4)

    4 - BioCardia, Inc. (0000925741) (Issuer)

    2/4/26 5:47:41 PM ET
    $BCDA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $ABSI
    $ADAG
    $AGAE
    $AGFY
    SEC Filings

    View All

    SEC Form 424B3 filed by C3is Inc.

    424B3 - C3is Inc. (0001951067) (Filer)

    2/19/26 9:26:22 AM ET
    $CISS
    Marine Transportation
    Consumer Discretionary

    SEC Form 424B3 filed by C3is Inc.

    424B3 - C3is Inc. (0001951067) (Filer)

    2/19/26 9:24:47 AM ET
    $CISS
    Marine Transportation
    Consumer Discretionary

    SEC Form 424B3 filed by C3is Inc.

    424B3 - C3is Inc. (0001951067) (Filer)

    2/19/26 9:23:27 AM ET
    $CISS
    Marine Transportation
    Consumer Discretionary

    $ABSI
    $ADAG
    $AGAE
    $AGFY
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Pivotal Research Group reiterated coverage on Alphabet with a new price target

    Pivotal Research Group reiterated coverage of Alphabet with a rating of Buy and set a new price target of $420.00 from $400.00 previously

    2/5/26 7:03:04 AM ET
    $GOOG
    Computer Software: Programming Data Processing
    Technology

    H.C. Wainwright resumed coverage on Hut 8 Mining with a new price target

    H.C. Wainwright resumed coverage of Hut 8 Mining with a rating of Buy and set a new price target of $80.00

    2/2/26 6:51:37 AM ET
    $HUT
    Finance: Consumer Services
    Finance

    KeyBanc Capital Markets reiterated coverage on Alphabet A with a new price target

    KeyBanc Capital Markets reiterated coverage of Alphabet A with a rating of Overweight and set a new price target of $360.00 from $330.00 previously

    1/26/26 10:43:23 AM ET
    $GOOGL
    Computer Software: Programming Data Processing
    Technology

    $ABSI
    $ADAG
    $AGAE
    $AGFY
    Leadership Updates

    Live Leadership Updates

    View All

    Celsius Holdings Appoints Christy Jacoby and John Short to the Company's Board of Directors

    Celsius Holdings, Inc. (NASDAQ:CELH) ("Celsius Holdings" or "the Company") today announced the appointment of Christy Jacoby and John Short to its Board of Directors. Jacoby and Short were nominated by PepsiCo, Inc. ("PepsiCo") following the resignation of Israel Kontorovsky and Michael Del Pozzo from the Celsius Holdings Board, effective immediately. "We thank Israel and Mike for their service and contributions during an important period of growth and evolution for Celsius Holdings," said John Fieldly, Chairman and Chief Executive Officer of Celsius Holdings. "As we continue to scale with discipline, operating rigor and portfolio clarity, we believe Christy and John bring highly relevant

    2/10/26 4:30:00 PM ET
    $CELH
    Beverages (Production/Distribution)
    Consumer Staples

    Chegg Appoints Karine Allouche as General Manager, Language Learning, Worldwide and Skills Integration, Europe

    Chegg, Inc. (NYSE:CHGG), a global learning company, today announced that Karine Allouche will join Busuu, Chegg's language learning business, as General Manager of Language Learning, Worldwide, and Skills Integration, Europe, effective February 9, 2026. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260209423954/en/Karine Allouche In her role, Karine will focus on strengthening execution, accelerating growth, and deepening collaboration across the company, in partnership with Chegg's leadership team and the board. In addition to leading language learning, Karine will own Chegg's European commercial engine and play a key role in

    2/9/26 9:05:00 AM ET
    $CHGG
    Other Consumer Services
    Real Estate

    Ally Appoints Distinguished Financial Services Executive and Former Regulator Rodney Hood as Senior Policy Advisor to the CEO

    CHARLOTTE, N.C., Jan. 27, 2026 /PRNewswire/ -- Ally Financial Inc. (NYSE:ALLY) today announced the appointment of Rodney Hood as a senior policy advisor to the CEO. In this role, Hood will leverage his nearly three decades of leadership in banking, regulation, risk management and financial inclusion to provide invaluable counsel on political affairs and D.C. engagement, further strengthening Ally's voice in critical policy discussions.  Hood brings an unparalleled depth of experience to Ally, having held multiple presidential appointments across two administrations. He notably

    1/27/26 10:00:00 AM ET
    $ALLY
    Major Banks
    Finance

    $ABSI
    $ADAG
    $AGAE
    $AGFY
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by NewAmsterdam Pharma Company N.V.

    SC 13D/A - NewAmsterdam Pharma Co N.V. (0001936258) (Subject)

    12/17/24 5:35:24 PM ET
    $NAMS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13D/A filed by NewAmsterdam Pharma Company N.V.

    SC 13D/A - NewAmsterdam Pharma Co N.V. (0001936258) (Subject)

    12/17/24 4:00:47 PM ET
    $NAMS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13D/A filed by NewAmsterdam Pharma Company N.V.

    SC 13D/A - NewAmsterdam Pharma Co N.V. (0001936258) (Subject)

    12/17/24 10:28:58 AM ET
    $NAMS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ABSI
    $ADAG
    $AGAE
    $AGFY
    Financials

    Live finance-specific insights

    View All

    C3is Inc. reports fourth quarter and twelve months 2025 financial and operating results

    ATHENS, Greece, Feb. 19, 2026 (GLOBE NEWSWIRE) -- C3is Inc. (NASDAQ:CISS) (the "Company"), a ship-owning company providing drybulk and tanker seaborne transportation services, announced today its unaudited financial and operating results for the fourth quarter and twelve months ended December 31, 2025. OPERATIONAL AND FINANCIAL HIGHLIGHTS Our handysize dry bulk carriers are on time charters of short-term durations, producing steady cash flows, while our Aframax tanker operates in the spot market, currently achieving voyage charter rates of around $60,000 per day.All of our vessels are unencumbered.Fleet operational utilization of 93.5% for the three months ended December 31, 2025, compar

    2/19/26 9:10:00 AM ET
    $CISS
    Marine Transportation
    Consumer Discretionary

    C3is Inc. reports fourth quarter and twelve months 2025 financial and operating results

    ATHENS, Greece, Feb. 19, 2026 (GLOBE NEWSWIRE) -- C3is Inc. (NASDAQ:CISS) (the "Company"), a ship-owning company providing drybulk and tanker seaborne transportation services, announced today its unaudited financial and operating results for the fourth quarter and twelve months ended December 31, 2025. OPERATIONAL AND FINANCIAL HIGHLIGHTS Our handysize dry bulk carriers are on time charters of short-term durations, producing steady cash flows, while our Aframax tanker operates in the spot market, currently achieving voyage charter rates of around $60,000 per day.All of our vessels are unencumbered.Fleet operational utilization of 93.5% for the three months ended December 31, 2025, compar

    2/19/26 9:10:00 AM ET
    $CISS
    Marine Transportation
    Consumer Discretionary

    Wayfair Announces Fourth Quarter and Full Year 2025 Results, Reports Further Share Capture and Strong Profitability

    Q4 Net Revenue of $3.3 billion with 21.3 million Active CustomersBOSTON, Feb. 19, 2026 /PRNewswire/ -- Wayfair Inc. ("Wayfair," "we," or "our") (NYSE:W), the destination for all things home, today reported financial results for its fourth quarter and full year ended December 31, 2025. Fourth Quarter 2025 Financial HighlightsTotal net revenue of $3.3 billion, increased $216 million, up 6.9% year over year. Total net revenue excluding the impact of our exit from the German market grew 7.8% year over yearU.S. net revenue of $2.9 billion, increased $202 million, up 7.4% year over ye

    2/19/26 7:00:00 AM ET
    $W
    Catalog/Specialty Distribution
    Consumer Discretionary

    $ABSI
    $ADAG
    $AGAE
    $AGFY
    Insider purchases explained

    Analytical look into recent insider purchases

    View All

    Investment Alert: Stock Acquired at Allied Gaming & Entertainment Inc. on Jul 4

    Recently, on July 4, 2024, a significant insider purchase was recorded at Allied Gaming & Entertainment Inc. as Large owner Choi Roy bought $456,750 worth of shares (360,000 units at $1.27), increasing direct ownership by 14% to 2,871,822 units (SEC Form 4). This purchase is notable for the size of the transaction and the percentage increase in direct ownership, indicating a strong belief in the company's future prospects. Insider purchases are generally viewed positively by investors as they signal confidence from those with intimate knowledge of the company's operations. Examining other recent insider transactions at Allied Gaming & Entertainment Inc., we notice a few patterns worth explo

    7/4/24 9:02:21 PM ET
    $AGAE
    Services-Misc. Amusement & Recreation
    Consumer Discretionary